{"id":746126,"date":"2026-08-18T01:03:41","date_gmt":"2026-08-18T06:03:41","guid":{"rendered":"https:\/\/www.capgemini.com\/us-en\/?p=746126&#038;preview=true&#038;preview_id=746126"},"modified":"2026-08-18T01:03:45","modified_gmt":"2026-08-18T06:03:45","slug":"reimagining-pharma-rd-with-generative-ai","status":"publish","type":"post","link":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/","title":{"rendered":"Reimagining pharma R&#038;D with generative AI"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-blogs header-hero-blogs\"><div class=\"container\"><div class=\"hero-blogs\"><div class=\"hero-blogs-content-wrapper\"><div class=\"row\"><div class=\"col-12\"><div class=\"header-title\"><h1>Reimagining Pharma R&amp;D with Generative AI<\/h1><\/div><\/div><\/div><\/div><div class=\"hero-blogs-bottom\"><div class=\"header-author\"><div class=\"author-img\"><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/06\/robm2022b.jpg?w=200&amp;quality=10\" alt=\"\" loading=\"lazy\"\/><\/div><div class=\"author-name-date\"><h5 class=\"author-name\">Dr Mark Roberts<\/h5><h5 class=\"blog-date\">Apr 11, 2025<\/h5><\/div><\/div><div class=\"brand-image\"><\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"grid-container\"><div class=\"col-12 col-md-2\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/?p=1117348\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/shareArticle?url=https:\/\/www.capgemini.com\/?p=1117348\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div><div class=\"article-text article-quote-text\">\n<p class=\"wp-block-paragraph\">The convergence of biology and technology has unlocked unprecedented scientific breakthroughs. Fueled by data science and artificial intelligence, bio-innovation is reaching new heights. And Generative AI is poised to be a catalyst of this bio-revolution &#8211; a transformative force that promises to accelerate discovery, enhance precision, and optimize operations across the pharmaceutical value chain.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For decades, the challenges of drug development have seemed to be set in stone: it takes well over a decade and <a href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2762311\" target=\"_blank\" rel=\"noreferrer noopener\">costs upwards of $1 billion<\/a> to bring a new drug to market. Even then<a href=\"http:\/\/refhub.elsevier.com\/S1359-6446(24)00397-0\/h0045\" target=\"_blank\" rel=\"noreferrer noopener\">, 90% of potential treatments fail<\/a> somewhere along the way. But what if we could rewrite this equation?<\/p>\n\n\n\n<h2 id=\"h-reimagining-drug-discovery-ai-as-the-co-scientist\" class=\"wp-block-heading\"><strong>Reimagining Drug Discovery: AI as the Co-scientist<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">At the heart of every breakthrough medicine is a molecule\u2014a tiny structure with the power to change lives. Finding the right molecule, however, has traditionally been a laborious process of trial and error, relying on time-consuming screening, costly experiments, and unpredictable outcomes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GenAI is redefining drug discovery with deep learning models trained on vast chemical and biological datasets that predict promising candidates as well as identifying drug targets with unprecedented accuracy. These AI-driven systems don\u2019t just analyze known compounds; they can design entirely new molecules, simulate their interactions, and flag potential failures before they reach the lab.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For pharmaceutical innovators, this means not only shortening R&amp;D timelines but also expanding the pipeline of high-quality drug candidates, reducing the risks associated with late-stage failures. In an industry where speed and accuracy are everything, AI is shifting the balance from guesswork to data-driven certainty.<\/p>\n\n\n\n<h2 id=\"h-revolutionizing-clinical-trials-smarter-faster-more-predictive\" class=\"wp-block-heading\"><strong>Revolutionizing Clinical Trials: Smarter, Faster, More Predictive<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Clinical trials remain a bottleneck in drug development. Recruiting the right patients, ensuring trial adherence, and managing vast amounts of regulatory data all contribute to delays and rising costs. Here, too, AI is proving to be a game-changer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">AI-powered models can now identify ideal patient subpopulations by analyzing real-world data, ensuring trials enroll individuals who are most likely to respond positively. This not only improves success rates but also lays the groundwork for precision medicine, where treatments are tailored to specific genetic or biomarker profiles.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Meanwhile, AI-generated synthetic data is reducing dependence on traditional control groups, allowing trials to run faster and with greater statistical power.&nbsp;GenAI-assisted automation is also transforming the regulatory process\u2014drafting protocols, ensuring compliance, and streamlining interactions with health authorities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For pharma executives, this means fewer trial failures, faster regulatory approvals, and a clearer path to market success.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201dThe promise of AI in the life-sciences is to transform it from an industry focused on hunting for ever-smaller needles in ever-larger haystacks, to one where new therapies are purposely designed and engineered with precision\u201d \u2013 Dr Mark Roberts, CTO Applied Sciences, Capgemini Engineering\u201d<\/p>\n\n\n\n<h2 id=\"h-beyond-the-lab-ai-optimized-manufacturing-and-digital-therapeutics\" class=\"wp-block-heading\"><strong>Beyond the Lab: AI-Optimized Manufacturing and Digital Therapeutics<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">While much of AI\u2019s promise lies in discovery and trials, its impact extends into pharmaceutical manufacturing and patient engagement.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">AI-driven predictive analytics are optimizing production processes, reducing waste, and improving scalability, making drug manufacturing leaner and more sustainable. Given the growing emphasis on ESG (Environmental, Social, and Governance) initiatives, AI-driven efficiency gains are not just about cost savings\u2014they\u2019re also about meeting global sustainability targets.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">At the same time, the rise of digital therapeutics (DTx) is redefining how we think about patient care. AI-powered applications are enabling personalized health interventions, from managing chronic diseases to real-time medication adjustments. As pharma companies explore hybrid models that combine traditional therapeutics with AI-driven digital health solutions, new revenue streams and business models are beginning to emerge.<\/p>\n\n\n\n<h2 id=\"h-the-ai-powered-pharma-enterprise-what-comes-next\" class=\"wp-block-heading\"><strong>The AI-Powered Pharma Enterprise: What Comes Next?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Despite the promise of GenAI, pharma organizations must take strategic steps to unlock its full potential. Investing in AI-first R&amp;D strategies, curating high-quality data ecosystems, and fostering AI-literate teams will be critical to long-term success. Regulatory frameworks must evolve alongside AI capabilities, ensuring ethical AI adoption and transparent validation of AI-driven discoveries.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The question is no longer <em>if<\/em> AI will transform pharma R&amp;D\u2014it already is. The real challenge is how quickly organizations can adapt. In the life-sciences, and other complex industries, autonomous and agentic systems will soon start to challenge existing norms and shorten value chains. Those who act now will define the future of medicine, setting new standards for speed, precision, and impact. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">AI isn\u2019t just changing the way we develop drugs\u2014it\u2019s reshaping the very fabric of healthcare. Are we ready to embrace this transformation?<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1359644624003970\" target=\"_blank\" rel=\"noreferrer noopener\">Click here<\/a> <\/strong>to read the research paper.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>About&nbsp;<em>AI&nbsp;<\/em>Futures Lab&nbsp;<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>We are the AI Futures Lab, expert partners that help you confidently visualize and pursue a better, sustainable, and trusted AI-enabled future. We do this by understanding, pre-empting, and harnessing emerging trends and technologies. Ultimately, making possible trustworthy and reliable AI that triggers your imagination, enhances your productivity, and increases your efficiency. We will support you with the business challenges you know about and the emerging ones you will need to know to succeed in the future.&nbsp; &nbsp;We create blogs, like this one, Points of View (POVs), and demos around these focus areas to start a conversation about how AI will impact us in the future. For more information on the AI Lab and more of the work we have done, visit this page: AI<a href=\"https:\/\/www.capgemini.com\/about-us\/who-we-are\/innovation-ecosystem\/aifutures\/\" target=\"_blank\" rel=\"noreferrer noopener\">&nbsp;Lab<\/a>.\u202f<\/em><a id=\"_msocom_1\"><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a id=\"_msocom_7\"><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\" section section--expert-slider wrapper-people-slider wp-block-cg-blocks-wrapper-people-slider undefined\"><div class=\"container\"><div class=\"row\"><div class=\"content-title col-12 col-md-8\"><h2 data-maxlength=\"34\" class=\"people-heading-title\">Meet the author<\/h2><\/div><\/div><\/div><div class=\"slider slider-boxed\"><div class=\"container\"><div class=\"slider-window\"><div class=\"slider-list\"><\/div><\/div><\/div><div class=\"slider-nav\"><button class=\"slider-prev inactive\" aria-label=\"Slider-previous\" tabindex=\"-1\"><\/button><ul class=\"slider-paginator\"><\/ul><button class=\"slider-next\" aria-label=\"Slider-next\"><\/button><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>The convergence of biology and technology has unlocked unprecedented scientific breakthroughs. Fueled by data science and artificial intelligence, bio-innovation is reaching new heights. And Generative AI is poised to be a catalyst of this bio-revolution &#8211; a transformative force that promises to accelerate discovery, enhance precision, and optimize operations across the pharmaceutical value chain.<\/p>\n","protected":false},"author":263,"featured_media":746127,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":false,"cg_dt_link_disabled":false,"_yoast_wpseo_primary_brand":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","featured_focal_points":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"brand":[],"service":[],"industry":[],"partners":[],"blog-topic":[380,285],"content-group":[],"class_list":["post-746126","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","blog-topic-healthcare","blog-topic-innovation"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Reimagining pharma R&amp;D with generative AI - Capgemini USA<\/title>\n<meta name=\"description\" content=\"The convergence of biology and technology has unlocked unprecedented scientific breakthroughs. Fueled by data science and artificial intelligence, bio-innovation is reaching new heights. And Generative AI is poised to be a catalyst of this bio-revolution - a transformative force that promises to accelerate discovery, enhance precision, and optimize operations across the pharmaceutical value chain.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reimagining pharma R&amp;D with generative AI\" \/>\n<meta property=\"og:description\" content=\"The convergence of biology and technology has unlocked unprecedented scientific breakthroughs. Fueled by data science and artificial intelligence, bio-innovation is reaching new heights. And Generative AI is poised to be a catalyst of this bio-revolution - a transformative force that promises to accelerate discovery, enhance precision, and optimize operations across the pharmaceutical value chain.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini USA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Capgemini\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-18T06:03:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-18T06:03:45+00:00\" \/>\n<meta name=\"author\" content=\"Dr Mark Roberts\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/04\/blog-banner.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"bedantadas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":[\"Article\",\"BlogPosting\"],\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/\"},\"author\":{\"name\":\"bedantadas\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/#\\\/schema\\\/person\\\/92b703c24b5deab19d42ae983e58f9d0\"},\"headline\":\"Reimagining pharma R&#038;D with generative AI\",\"datePublished\":\"2026-08-18T06:03:41+00:00\",\"dateModified\":\"2026-08-18T06:03:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/\"},\"wordCount\":901,\"publisher\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/wp-content\\\/uploads\\\/sites\\\/30\\\/2025\\\/04\\\/blog-banner.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/\",\"url\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/\",\"name\":\"Reimagining pharma R&D with generative AI - Capgemini USA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/wp-content\\\/uploads\\\/sites\\\/30\\\/2025\\\/04\\\/blog-banner.jpg\",\"datePublished\":\"2026-08-18T06:03:41+00:00\",\"dateModified\":\"2026-08-18T06:03:45+00:00\",\"description\":\"The convergence of biology and technology has unlocked unprecedented scientific breakthroughs. Fueled by data science and artificial intelligence, bio-innovation is reaching new heights. And Generative AI is poised to be a catalyst of this bio-revolution - a transformative force that promises to accelerate discovery, enhance precision, and optimize operations across the pharmaceutical value chain.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/wp-content\\\/uploads\\\/sites\\\/30\\\/2025\\\/04\\\/blog-banner.jpg\",\"contentUrl\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/wp-content\\\/uploads\\\/sites\\\/30\\\/2025\\\/04\\\/blog-banner.jpg\",\"width\":2880,\"height\":1800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/insights\\\/expert-perspectives\\\/reimagining-pharma-rd-with-generative-ai\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reimagining pharma R&#038;D with generative AI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/#website\",\"url\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/\",\"name\":\"Capgemini\",\"description\":\"Just another www.capgemini.com site\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/#organization\",\"name\":\"Capgemini\",\"url\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":null,\"contentUrl\":null,\"width\":null,\"height\":null,\"caption\":\"Capgemini\"},\"image\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Capgemini\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/capgemini\",\"https:\\\/\\\/www.instagram.com\\\/capgemini\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/capgeminimedia\",\"https:\\\/\\\/www.glassdoor.com\\\/Overview\\\/Working-at-Capgemini-EI_IE3803.11,20.htm\"],\"description\":\"Businesses everywhere are transforming. AI and cutting-edge technologies have created a groundswell of opportunities, new sources of long-term value and resilience. Capgemini is at the heart of this new technology revolution, partnering with clients in every sector to deliver real, sustainable transformation at scale. Collaborating across multiple business and tech ecosystems, our team of 420,000 experts in more than 50 countries unleashes human energy through technology and AI for an inclusive and sustainable future. Fostering agility, leveraging creativity, and maximizing competitiveness, Capgemini is the partner of choice for the businesses and organizations of tomorrow, helping our clients unlock the value of technology that will define their success in the decades to come.\",\"legalName\":\"Capgemini\",\"foundingDate\":\"1967-10-01\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"5001\",\"maxValue\":\"10000\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/#\\\/schema\\\/person\\\/92b703c24b5deab19d42ae983e58f9d0\",\"name\":\"bedantadas\",\"url\":\"https:\\\/\\\/www.capgemini.com\\\/us-en\\\/author\\\/bedantadas\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Reimagining pharma R&D with generative AI - Capgemini USA","description":"The convergence of biology and technology has unlocked unprecedented scientific breakthroughs. Fueled by data science and artificial intelligence, bio-innovation is reaching new heights. And Generative AI is poised to be a catalyst of this bio-revolution - a transformative force that promises to accelerate discovery, enhance precision, and optimize operations across the pharmaceutical value chain.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/","og_locale":"en_US","og_type":"article","og_title":"Reimagining pharma R&D with generative AI","og_description":"The convergence of biology and technology has unlocked unprecedented scientific breakthroughs. Fueled by data science and artificial intelligence, bio-innovation is reaching new heights. And Generative AI is poised to be a catalyst of this bio-revolution - a transformative force that promises to accelerate discovery, enhance precision, and optimize operations across the pharmaceutical value chain.","og_url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/","og_site_name":"Capgemini USA","article_publisher":"https:\/\/www.facebook.com\/Capgemini\/","article_published_time":"2026-08-18T06:03:41+00:00","article_modified_time":"2026-08-18T06:03:45+00:00","author":"Dr Mark Roberts","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/04\/blog-banner.jpg","twitter_misc":{"Written by":"bedantadas","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/#article","isPartOf":{"@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/"},"author":{"name":"bedantadas","@id":"https:\/\/www.capgemini.com\/us-en\/#\/schema\/person\/92b703c24b5deab19d42ae983e58f9d0"},"headline":"Reimagining pharma R&#038;D with generative AI","datePublished":"2026-08-18T06:03:41+00:00","dateModified":"2026-08-18T06:03:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/"},"wordCount":901,"publisher":{"@id":"https:\/\/www.capgemini.com\/us-en\/#organization"},"image":{"@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/04\/blog-banner.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/","url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/","name":"Reimagining pharma R&D with generative AI - Capgemini USA","isPartOf":{"@id":"https:\/\/www.capgemini.com\/us-en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/04\/blog-banner.jpg","datePublished":"2026-08-18T06:03:41+00:00","dateModified":"2026-08-18T06:03:45+00:00","description":"The convergence of biology and technology has unlocked unprecedented scientific breakthroughs. Fueled by data science and artificial intelligence, bio-innovation is reaching new heights. And Generative AI is poised to be a catalyst of this bio-revolution - a transformative force that promises to accelerate discovery, enhance precision, and optimize operations across the pharmaceutical value chain.","breadcrumb":{"@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/#primaryimage","url":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/04\/blog-banner.jpg","contentUrl":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/04\/blog-banner.jpg","width":2880,"height":1800},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-pharma-rd-with-generative-ai\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.capgemini.com\/us-en\/"},{"@type":"ListItem","position":2,"name":"Reimagining pharma R&#038;D with generative AI"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/us-en\/#website","url":"https:\/\/www.capgemini.com\/us-en\/","name":"Capgemini","description":"Just another www.capgemini.com site","publisher":{"@id":"https:\/\/www.capgemini.com\/us-en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/us-en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.capgemini.com\/us-en\/#organization","name":"Capgemini","url":"https:\/\/www.capgemini.com\/us-en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.capgemini.com\/us-en\/#\/schema\/logo\/image\/","url":null,"contentUrl":null,"width":null,"height":null,"caption":"Capgemini"},"image":{"@id":"https:\/\/www.capgemini.com\/us-en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Capgemini\/","https:\/\/www.linkedin.com\/company\/capgemini","https:\/\/www.instagram.com\/capgemini\/","https:\/\/www.youtube.com\/user\/capgeminimedia","https:\/\/www.glassdoor.com\/Overview\/Working-at-Capgemini-EI_IE3803.11,20.htm"],"description":"Businesses everywhere are transforming. AI and cutting-edge technologies have created a groundswell of opportunities, new sources of long-term value and resilience. Capgemini is at the heart of this new technology revolution, partnering with clients in every sector to deliver real, sustainable transformation at scale. Collaborating across multiple business and tech ecosystems, our team of 420,000 experts in more than 50 countries unleashes human energy through technology and AI for an inclusive and sustainable future. Fostering agility, leveraging creativity, and maximizing competitiveness, Capgemini is the partner of choice for the businesses and organizations of tomorrow, helping our clients unlock the value of technology that will define their success in the decades to come.","legalName":"Capgemini","foundingDate":"1967-10-01","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"5001","maxValue":"10000"}},{"@type":"Person","@id":"https:\/\/www.capgemini.com\/us-en\/#\/schema\/person\/92b703c24b5deab19d42ae983e58f9d0","name":"bedantadas","url":"https:\/\/www.capgemini.com\/us-en\/author\/bedantadas\/"}]}},"blog_topic_info":[{"id":380,"name":"Healthcare"},{"id":285,"name":"Innovation"}],"taxonomy_info":{"category":[{"id":1,"name":"Uncategorized","slug":"uncategorized"}],"blog-topic":[{"id":380,"name":"Healthcare","slug":"healthcare"},{"id":285,"name":"Innovation","slug":"innovation"}]},"archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/04\/blog-banner.jpg","featured_image_alt":"","jetpack-related-posts":[{"id":763907,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-rise-of-techbio-and-rds-evolving-operating-models\/","url_meta":{"origin":746126,"position":0},"title":"The rise of TechBio and R&#038;D\u2019s evolving operating models","author":"Soumya Kanti Mondal","date":"May 20, 2026","format":false,"excerpt":"How TechBio\u2019s integrated, AI-driven R&D model contrasts with traditional pharma\u2019s siloed approach, and what it takes to combine both for faster scaling.","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"pharma R&D","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":766422,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/reimagining-hcp-engagement-strategies-for-a-digital-first-future-5-ideas-from-life-sciences-industry-experts\/","url_meta":{"origin":746126,"position":1},"title":"Reimagining HCP engagement strategies for a digital-first future: 5 ideas from life sciences industry experts","author":"elishavalekar","date":"March 17, 2026","format":false,"excerpt":"Reimagining HCP engagement strategies for a digital-first future: 5 ideas from life sciences industry experts","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/08\/JPM-design-2880-x1880-px-dotcom-Banner-1.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/08\/JPM-design-2880-x1880-px-dotcom-Banner-1.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/08\/JPM-design-2880-x1880-px-dotcom-Banner-1.webp?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":748949,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/the-future-of-pharma-mes\/","url_meta":{"origin":746126,"position":2},"title":"The future of pharma MES","author":"elishavalekar","date":"July 8, 2025","format":false,"excerpt":"In our previous blog, we discussed the current state of Manufacturing Execution Systems (MES) in the pharmaceutical industry, highlighting the challenges and limitations faced today.","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/07\/Blog2-Pharma-MES-2880-x1880-px-dotcom-Banner.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":765609,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/rewiring-early-drug-development-with-ai-and-digitalization\/","url_meta":{"origin":746126,"position":3},"title":"Rewiring early drug development with AI and digitalization","author":"Soumya Kanti Mondal","date":"June 25, 2026","format":false,"excerpt":"Exploring AI and digitalization\u2019s potential to overcome time-consuming, costly, and risky early-stage drug discovery and development.","rel":"","context":"In \"ai in drug\"","block_context":{"text":"ai in drug","link":"https:\/\/www.capgemini.com\/us-en\/tag\/ai-in-drug\/"},"img":{"alt_text":"pharma R&D","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/05\/LS-Pharma-RD-Web-banner.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":731820,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/key-takeaways-from-biotechx-2024-a-shift-towards-realism-and-practical-applications\/","url_meta":{"origin":746126,"position":4},"title":"Key Takeaways from BioTechX 2024: A Shift Towards Realism and Practical Applications","author":"elishavalekar","date":"November 19, 2024","format":false,"excerpt":"Key Takeaways from BioTechX 2024: A Shift Towards Realism and Practical ApplicationsCapgeminiNov 6, 2024 FacebookLinkedinThe BioTechX event in Basel in October was a major gathering for biotech and pharma professionals. This year, there was a different vibe compared to last year. This year's event marked a noticeable shift from the\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2024\/11\/GettyImages-1090243542.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2024\/11\/GettyImages-1090243542.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2024\/11\/GettyImages-1090243542.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2024\/11\/GettyImages-1090243542.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2024\/11\/GettyImages-1090243542.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2024\/11\/GettyImages-1090243542.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":763061,"url":"https:\/\/www.capgemini.com\/us-en\/insights\/expert-perspectives\/jpm-healthcare-2026-signals-shaping-the-next-era-of-life-sciences-innovation\/","url_meta":{"origin":746126,"position":5},"title":"JPM Healthcare 2026: Signals shaping the next era of life sciences innovation","author":"elishavalekar","date":"February 11, 2026","format":false,"excerpt":"JPM Healthcare 2026 revealed a sector at a strategic inflection point. While headline announcements were fewer, the signals were louder: M&A is returning with purpose, AI has firmly crossed into production\u2011grade infrastructure, and pharma\u2019s role in care delivery is rapidly expanding. The conversations across San Francisco made one thing clear\u2014leaders\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/04\/Hero-VI-Detox-Breakfast-event.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/04\/Hero-VI-Detox-Breakfast-event.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/04\/Hero-VI-Detox-Breakfast-event.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/04\/Hero-VI-Detox-Breakfast-event.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/04\/Hero-VI-Detox-Breakfast-event.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2026\/04\/Hero-VI-Detox-Breakfast-event.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini USA","distributor_original_site_url":"https:\/\/www.capgemini.com\/us-en","push-errors":false,"jetpack_featured_media_url":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/04\/blog-banner.jpg","featured_image_url":"https:\/\/www.capgemini.com\/us-en\/wp-content\/uploads\/sites\/30\/2025\/04\/blog-banner.jpg","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/posts\/746126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/users\/263"}],"replies":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/comments?post=746126"}],"version-history":[{"count":1,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/posts\/746126\/revisions"}],"predecessor-version":[{"id":767442,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/posts\/746126\/revisions\/767442"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/media\/746127"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/media?parent=746126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/categories?post=746126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/tags?post=746126"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/brand?post=746126"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/service?post=746126"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/industry?post=746126"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/partners?post=746126"},{"taxonomy":"blog-topic","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/blog-topic?post=746126"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/us-en\/wp-json\/wp\/v2\/content-group?post=746126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}